Table 1.
Participant characteristics stratified by age (<80 years, n = 86; ≥80 years, n = 69).
| <80 Years | ≥80 Years | |
|---|---|---|
| Age (years) | 78 (5.7) | 86 (3.5) |
| Females | 53 (60.9) | 36 (52.9) |
| Caucasian ethnicity | 66 (79.5) | 61 (93.8) |
| Lives alone (%) | 13 (14.9) | 23 (33.8) |
| History of other medical conditions (%): | ||
| Heart attack (%) | 7 (8.0) | 10 (14.7) |
| Angina (%) | 4 (4.6) | 2 (2.9) |
| Other cardiac (%) | 21 (24) | 21 (30.9) |
| Stroke/Transient Ischemic Attack (%) | 3 (3.4) | 12 (17.6) |
| High blood pressure (%) | 56 (64.4) | 42 (61.8) |
| High cholesterol (%) | 42 (48.3) | 37 (54.4) |
| Diabetes/pre-diabetes (%) | 21 (24.1) | 15 (22.1) |
| Kidney disease (%) | 6 (6.9) | 4 (5.9) |
| Arthritis (%) | 40 (46.0) | 41 (60.3) |
| Other illness or major operation (%) | 54 (62.1) | 45 (66.2) |
| History of cataracts (%) | 52 (59.8) | 63 (92.6) |
| History of glaucoma (%) | 9 (10.3) | 14 (20.6) |
| Type of AMD by eyes | N = 140 | N = 114 |
| No AMD (%) | 28 (20) | 22 (19) |
| Early AMD (%) | 6 (4.3) | 0 (0.0) |
| Dry AMD (%) | 24 (17) | 8 (7.0) |
| Wet AMD (%) | 70 (50) | 69 (61) |
| Dry and Wet (%) | 12 (8.6) | 15 (13) |
| Eyes with wet AMD, receiving treatment with | N = 79 | N = 80 |
| Eylea (%) | 54 (68) | 52 (65) |
| Lucentis (%) | 24 (30) | 28 (35) |
| Avastin (%) | 1 (1.3) | 0 (0.0) |
All data are presented as n (%) or mean (SD). AMD: age-related macular degeneration.